上海正帆科技股份有限公司 2025 年第三季度报告 证券代码：688596 证券简称：正帆科技 转债代码：118053 转债简称：正帆转债 上海正帆科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 | | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | --- | | | | 本报告期比 | | 年初至报告期 | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | ...

| 证券代码：688596 | 证券简称：正帆科技 | 公告编号：2025-068 | | --- | --- | --- | | 转债代码：118053 | 转债简称：正帆转债 | | 上海正帆科技股份有限公司 关于 2025 年前三季度计提资产减值准备的公告 1 单位：人民币万元 项目 计提减值准备金额 信用减值损失 应收票据坏账损失 166.22 应收账款坏账损失 5,729.48 其他应收款坏账损失 0.22 资产减值损失 合同资产减值损失 134.07 存货跌价损失及合同履约 成本减值损失 1,069.43 合计 7,099.42 （二）资产减值损失 公司以预期信用损失为基础，对合同资产进行减值测试并确认损失准备，本 期计提合同资产减值损失为134.07万元。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本次计提减值准备情况概述 根据《企业会计准则》以及公司财务制度等相关规定，为客观公允地反映公 司截至2025年9月30日的财务状况及经营成果，基于谨慎性原则，对截至2025年9 月30日合并报表范围内可能 ...

| 证券代码：688596 | 证券简称：正帆科技 | 公告编号：2025-067 | | --- | --- | --- | | 转债代码：118053 | 转债简称：正帆转债 | | 上海正帆科技股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的提示性 公告 風帆控股有限公司保证向本公司提供的信息真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 1.身份类别 一、 信息披露义务人及其一致行动人的基本信息 | | 控股股东/实际控制人及其一致行动人 | | --- | --- | | | □其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | | 于无控股股东、实际控制人） | | | □其他______________（请注明） | 2.信息披露义务人信息 公司于近日收到風帆控股出具的《告知函》，風帆控股已累计减持 181,013,000 元人民币面值的"正帆转债"，本次减持后，風帆控股持有公司股 份 50,789,260 股，持有 0 元人民币 ...

Core Viewpoint - Zhengfan Technology (688596.SH) experienced a significant decline in stock price, dropping 5.52% to 37.99 yuan, marking a nearly one-month low since September 25, after reaching a historical high of 49.8 yuan on October 14 [1] Group 1: Stock Performance - The stock has seen a continuous decline for 8 trading days, accumulating a total drop of 23.71% [1] - The stock price reached a peak of 49.8 yuan on October 14 before rapidly falling [1] Group 2: Shareholder Actions - Director Huang Yong plans to reduce his holdings by up to 2,900,000 shares, representing no more than 0.9900% of the company's total shares, through centralized bidding and block trading [1] - Supervisor Zhou Mingzheng intends to reduce his holdings by up to 2,600,000 shares, representing no more than 0.8876% of the company's total shares, also through centralized bidding and block trading [1] - The reduction period for both shareholders is set from November 13, 2025, to February 12, 2026 [1]

Group 1 - Hengsheng Energy reported that its CVD diamond product revenue accounted for 0.15% of total revenue in the first half of 2025, amounting to 683,500 yuan [1][2] - Hengyi Petrochemical's project for an annual production of 1.2 million tons of caprolactam and polyamide integration has entered the trial production phase [1][2] - Beixin Road and Bridge won a public works construction project worth 399 million yuan [1][2] Group 2 - Harsen Co. plans to acquire 45% equity in Dongtai Hongyu for 27 million yuan [1][2] - Shennong Technology's board member Huang Yong intends to reduce his holdings by up to 2.9 million shares [1][2] - Haon Automotive Electric received a product designation letter, estimating total revenue of approximately 576 million yuan over its lifecycle [1][2] Group 3 - Coldray Mining reported a net profit of 238 million yuan for the first three quarters, representing a year-on-year increase of 42.57% [1][2] - Tonghuashun's net profit for the first three quarters reached 1.206 billion yuan, up 85.29% year-on-year [1][2] - Binhua Co. submitted an application for H-share listing on the Hong Kong Stock Exchange [1][2]

Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in investor confidence and market dynamics [1] Shareholder Reductions - Wan Ye Enterprise: Shareholder Sanlin Wan Ye plans to reduce a total of 5.2059 million shares [1] - Kesi Technology: Liang Hongjian intends to reduce 1% of the company's shares [1] - Jindan Technology: Guangzhou Chengxin plans to reduce no more than 2.3866 million shares [1] - Xuantai Pharmaceutical: Qihe Venture plans to reduce a total of 3.131 million shares [1] - Hangzhou Jiebai: Chairman and General Manager Bi Ling plans to reduce a total of no more than 375,000 shares [1] - Jialian Biological: Shareholder UBI plans to reduce no more than 3% of shares [1] - Puyuan Information: Liu Yadong and his concerted actions plan to reduce a total of 0.89% of shares [1] - Zhifan Technology: Director Huang Yong plans to reduce no more than 2.9 million shares [1] - Lanshi Heavy Industry: Shareholder Hualing Xianggang plans to reduce no more than 1% of shares [1] - Biyi Micro: Shareholder Fang Guang Erqi plans to reduce a total of 1.50% of shares [1] - Xinghuo Technology: Shareholder Tie Xiaorong plans to reduce a total of 37.2298 million shares [1] - Henglian Shares: Multiple shareholders plan to reduce their stakes [1] - Jucheng Shares: Wuhan Luojia plans to reduce a total of 4.1241 million shares [1] Financial Performance - Xuanji Information: Reported a net loss of 173 million yuan for the first three quarters [1] - Meilixin: Reported a net loss of 110 million yuan for the third quarter [1]

Core Viewpoint - The announcement details the share reduction plans of board member Huang Yong and supervisor Zhou Mingzheng of Shanghai Zhengfan Technology Co., Ltd due to personal financial needs [3][6]. Shareholding Information - As of the announcement date, board member Huang Yong holds 13,671,394 shares, representing 4.67% of the total share capital, while supervisor Zhou Mingzheng holds 12,671,394 shares, representing 4.33% of the total share capital [2][4]. Reduction Plan Details - Huang Yong plans to reduce his holdings by up to 2,900,000 shares, not exceeding 0.99% of the total shares, while Zhou Mingzheng plans to reduce by up to 2,600,000 shares, not exceeding 0.8876% of the total shares. The reduction will occur through centralized bidding and block trading within three months starting from November 13, 2025, to February 12, 2026 [3][5]. Compliance and Commitments - Both Huang Yong and Zhou Mingzheng have committed to long-term holding of the company's shares and will adhere to relevant laws and regulations during the reduction process. They have confirmed that the planned reductions are consistent with previous commitments made [6][8].

Group 1 - On October 22, no A-share listed companies disclosed any increase in shareholding [1] - A total of 10 A-share listed companies announced share reductions, including Tai Lingwei, Jindan Technology, Shenlian Biology, Qianyuan Pharmaceutical, Hengsheng Energy, Zhengfan Technology, Lanshi Heavy Industry, Haiguo Co., Ganfeng Lithium, and Hengsuo Co. [1] Group 2 - Tai Lingwei's second largest shareholder, the National Big Fund, plans to reduce its stake by no more than 2% [2] - Jindan Technology's shareholder, Guangzhou Chengxin, intends to reduce its stake by no more than 1.05% [2] - Shenlian Biology's shareholder, UB, plans to reduce its stake by no more than 3% [2] - Qianyuan Pharmaceutical's shareholder, Weng Zhangguo, intends to reduce its stake by no more than 3% [2] - Zhengfan Technology's directors and supervisors plan to collectively reduce their stake by no more than 1.88% [2] - Hengsheng Energy's actual controller has already reduced his stake by 501,600 shares [2] - Lanshi Heavy Industry's shareholder, Hualing Xianggang, plans to reduce its stake by no more than 1% [2] - Haiguo Co.'s shareholder, Yujian Chuangtou, intends to reduce its stake by no more than 0.9965% [2] - Ganfeng Lithium's vice president, Fu Lihua, plans to reduce his stake by no more than 40,000 shares [2] - Hengsuo Co.'s shareholders collectively plan to reduce their stake by no more than 3% [2]

Core Viewpoint - The article summarizes significant announcements from various listed companies in the Shanghai and Shenzhen stock markets, highlighting potential investment opportunities and risks based on recent developments and financial performance. Group 1: Company Announcements - Tianpu Co., Ltd. warns that its stock price has significantly deviated from its fundamentals, with a cumulative increase of 246.02% from August 22 to October 22, indicating a potential for rapid decline [4] - Shenzhen Sanda A plans to sell stakes in several subsidiaries to focus on its core business, including 80% of Zhongdian Continental Environmental Technology [5][6] - Zhongchong Co., Ltd. received an administrative regulatory measure from the Shandong Securities Regulatory Bureau for failing to announce a significant change in shareholding [7] - Construction Machinery has reported a net loss of 447 million yuan for the first half of 2025, marking three consecutive years of losses [8] - Junshi Biosciences announced that its subsidiary passed a recent FDA inspection, indicating compliance with CGMP standards [9] Group 2: Financial Performance - Duofuduo reported a net profit increase of 407.74% year-on-year for the first three quarters of 2025, with a revenue of 6.73 billion yuan [17] - Weihuaxincai achieved a net profit growth of 250.04% year-on-year in Q3, with revenues of 660 million yuan [18] - Guangdong Jianke reported a net profit increase of 190.62% year-on-year for the first three quarters, despite a revenue decline [19] - Xianggang Technology reported a net profit increase of 186.19% year-on-year for the first three quarters, with revenues of 742 million yuan [20] - Defu Technology reported a net profit increase of 132.63% year-on-year for the first three quarters, driven by increased copper foil sales [21] Group 3: Major Transactions and Investments - Tangrenshen plans to establish two investment funds with a total investment of 11.04 million yuan to focus on the agricultural sector [13] - Farsen intends to sell a 10% stake in Bekaert Steel Cord, constituting a major asset restructuring [14] - Shikong Technology plans to acquire 100% of Jiahe Jingwei, entering the storage sector [15] - Jiangsu New Energy's controlling shareholder is investing in offshore wind power projects and will manage the project companies [11][12] Group 4: Shareholder Actions - Qianyuan Pharmaceutical's shareholder plans to reduce its stake by up to 3% [42] - Zhengfan Technology's board members plan to collectively reduce their holdings by up to 1.88% [43]

Core Viewpoint - The company, Zhengfan Technology, announced a share reduction plan by its director and supervisor due to personal funding needs [1] Group 1: Share Reduction Details - Director Huang Yong plans to reduce his holdings by up to 2,900,000 shares, representing approximately 0.9900% of the company's total shares [1] - Supervisor Zhou Mingzheng intends to reduce his holdings by up to 2,600,000 shares, accounting for about 0.8876% of the company's total shares [1] - The share reduction will occur through centralized bidding and block trading, starting 15 trading days after the announcement and lasting from November 13, 2025, to February 12, 2026 [1]